Science
LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station – Business Wire
LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineer
FARMINGTON, Conn.–(BUSINESS WIRE)–LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineering partner Space Tango on Northrop Grummans 14th Commercial Resupply Services Mission for NASA (NG-14) to the International Space Station (ISS) U.S. National Laboratory. Scheduled to launch on September 30th at 2:26 UTC (10:26 p.m. ET), NG-14 is the first of a series of NASA flights to the ISS in low-Earth orbit…
-
General5 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business5 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General8 hours agoAlbanese beats drum on economy as trade clouds gather
-
General6 hours agoToo skewed, too gentlemanly | The Spectator Australia